This inventor holds 9 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Acura Pharmaceuticals, Inc.. Active years: 2007-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2016
Title: Inventor Spotlight: Dilip B. Wadgaonkar
Introduction
Dilip B. Wadgaonkar, based in Suffern, NY, is a notable inventor with an impressive portfolio of nine patents to his name. His work primarily focuses on pharmaceutical innovations that contribute to safer therapeutic applications.
Latest Patents
Among his most recent inventions are the "Abuse Deterrent Compositions and Methods of Making Same." This invention presents a therapeutic pharmaceutical composition consisting of a mixture that includes an opioid, polyethylene oxide in quantities ranging from 3% to 40% weight of the composition, a disintegrant, and a surfactant. The design ensures that the pharmaceutical composition exhibits an immediate release profile, which can enhance patient safety and medication adherence. Additionally, he has developed an abuse deterrent dosage form of opioid analgesics. This form aptly combines an analgesically effective amount of opioid analgesic with a polymer to create a protective matrix, designed to deter misuse.
Career Highlights
Dilip B. Wadgaonkar has built a substantial career at Acura Pharmaceuticals, Inc., where he contributes his expertise in developing innovative pharmaceutical solutions. His work has significantly impacted the medical field, particularly in the area of pain management and addiction prevention.
Collaborations
Throughout his career, Wadgaonkar has collaborated with esteemed colleagues, including Vijai Kumar and David Dixon. Together, they have advanced the dialogue and developments in pharmaceutical technology, showcasing the power of teamwork in fostering innovation.
Conclusion
Dilip B. Wadgaonkar's contributions highlight the importance of innovation in the pharmaceutical industry. His dedication to creating safer and more effective therapeutic compositions underscores the ongoing need for research and development in combating misuse of opioids. As he continues to push the boundaries of pharmaceutical inventions, Wadgaonkar remains a key figure to watch in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile